Cheryl Reicin will co-present "Licensing Issues in the Life Sciences Industry." Topics include

• Research plan
• Due diligence
• Transitioning pharmaceutical products/programs
• Monetary considerations (e.g., royalties, product returns, etc.)
• IP rights considerations (e.g., ownership, licenses, retained rights, patent term extensions)
• Clinical stage vs. commercialized products
• Government rights and approvals (e.g., march-in rights, clinical trials, FDA approvals)
• Deal structures and governance